Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention

The prevalence of statin use is high but adherence low. For public health intervention to be rational, subpopulations of nonadherent subjects must be defined. To categorise statin users with respect to patterns of reimbursement, this study was performed using the main French health reimbursement dat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fundamental & clinical pharmacology 2011-08, Vol.25 (4), p.528-533
Hauptverfasser: Latry, Philippe, Martin-Latry, Karin, Labat, Anne, Molimard, Mathieu, Peter, Claude
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 533
container_issue 4
container_start_page 528
container_title Fundamental & clinical pharmacology
container_volume 25
creator Latry, Philippe
Martin-Latry, Karin
Labat, Anne
Molimard, Mathieu
Peter, Claude
description The prevalence of statin use is high but adherence low. For public health intervention to be rational, subpopulations of nonadherent subjects must be defined. To categorise statin users with respect to patterns of reimbursement, this study was performed using the main French health reimbursement database for the Aquitaine region of south‐western France. The cohort included subjects who submitted a reimbursement for at least one delivery of a statin (index) during the inclusion period (1st of September 2004–31st of December 2004). Indicators of adherence from reimbursement data were considered for principal component analysis. The 119 570 subjects included and analysed had a sex ratio of 1.1, mean (SD) age of 65.9 (11.9), and 13% were considered incident statin users. Principal component analysis found three dimensions that explained 67% of the variance. Using a K‐means classification combined with a hierarchical ascendant classification, six groups were characterised. One group was considered nonadherent (10% of study population) and one group least adherent (1%). This novel application of principal component analysis identified groups that may be potential targets for intervention. The least adherent group appears to be one of the most appropriate because of both its relatively small size for case review with prescribing physicians and its very poor adherence.
doi_str_mv 10.1111/j.1472-8206.2010.00870.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_875487795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>875487795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4360-f99a2706fb5e676e5b3d5d6068c242af1b948b329d1be0a66d08e26d1c4cd2463</originalsourceid><addsrcrecordid>eNpFkc2O0zAUhS0EYsrAKyBvEKsU23HsBLFBEfMjFZgFI9hZjnNDXZw4xM7QvhJPiUNL8cbWOd-5lu5BCFOypum82a0plywrGRFrRpJKSCnJev8Irc7GY7QiUsgsr0p6gZ6FsCOESkLFU3TBqGQV5eUK_b4PgH2Hx8kOxo7aYeP70Q8wRKwH7Q7BBmwHHLeA4UG7WUfrhyWh2y1MMBjA0eMQk56oCXTsU_Yt1riHuPXt4rYQYertAEkdfUy-TR9FPX2HmIRxdsepnZ_wODfOGrwF7eI2_ZySD0vAD8_Rk067AC9O9yW6v_rwpb7JNp-vb-v3m8zwXJCsqyrNJBFdU4CQAoomb4tWEFEaxpnuaFPxsslZ1dIGiBaiJSUw0VLDTcu4yC_R6-PccfI_ZwhR9TYYcE4P4OegSlnwUsqqSOTLEzk3PbQqLbHX00H9W28CXp0AHYx23aTTksN_jueM5pwn7t2R-2UdHM4-JWqpW-3U0qpaWlVL3epv3Wqvruq79Ejx7Bi3IcL-HNfTDyVkLgv19dO1-laUH2u2qdVd_gfk5bA8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>875487795</pqid></control><display><type>article</type><title>Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Latry, Philippe ; Martin-Latry, Karin ; Labat, Anne ; Molimard, Mathieu ; Peter, Claude</creator><creatorcontrib>Latry, Philippe ; Martin-Latry, Karin ; Labat, Anne ; Molimard, Mathieu ; Peter, Claude</creatorcontrib><description>The prevalence of statin use is high but adherence low. For public health intervention to be rational, subpopulations of nonadherent subjects must be defined. To categorise statin users with respect to patterns of reimbursement, this study was performed using the main French health reimbursement database for the Aquitaine region of south‐western France. The cohort included subjects who submitted a reimbursement for at least one delivery of a statin (index) during the inclusion period (1st of September 2004–31st of December 2004). Indicators of adherence from reimbursement data were considered for principal component analysis. The 119 570 subjects included and analysed had a sex ratio of 1.1, mean (SD) age of 65.9 (11.9), and 13% were considered incident statin users. Principal component analysis found three dimensions that explained 67% of the variance. Using a K‐means classification combined with a hierarchical ascendant classification, six groups were characterised. One group was considered nonadherent (10% of study population) and one group least adherent (1%). This novel application of principal component analysis identified groups that may be potential targets for intervention. The least adherent group appears to be one of the most appropriate because of both its relatively small size for case review with prescribing physicians and its very poor adherence.</description><identifier>ISSN: 0767-3981</identifier><identifier>EISSN: 1472-8206</identifier><identifier>DOI: 10.1111/j.1472-8206.2010.00870.x</identifier><identifier>PMID: 21729148</identifier><identifier>CODEN: FCPHEZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Age Factors ; Aged ; Biological and medical sciences ; Cardiovascular Diseases - prevention &amp; control ; Cohort Studies ; Databases, Factual ; Drug Prescriptions - statistics &amp; numerical data ; Female ; France ; HMG CoA reductase inhibitors ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Insurance, Health, Reimbursement - statistics &amp; numerical data ; Male ; Medical sciences ; Medication Adherence - statistics &amp; numerical data ; Middle Aged ; Pharmacology. Drug treatments ; Principal Component Analysis ; public health ; Public Health Practice ; Sex Factors ; Time Factors</subject><ispartof>Fundamental &amp; clinical pharmacology, 2011-08, Vol.25 (4), p.528-533</ispartof><rights>2010 The Authors Fundamental and Clinical Pharmacology © 2010 Société Française de Pharmacologie et de Thérapeutique</rights><rights>2015 INIST-CNRS</rights><rights>2010 The Authors Fundamental and Clinical Pharmacology © 2010 Société Française de Pharmacologie et de Thérapeutique.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4360-f99a2706fb5e676e5b3d5d6068c242af1b948b329d1be0a66d08e26d1c4cd2463</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1472-8206.2010.00870.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1472-8206.2010.00870.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24321344$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21729148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Latry, Philippe</creatorcontrib><creatorcontrib>Martin-Latry, Karin</creatorcontrib><creatorcontrib>Labat, Anne</creatorcontrib><creatorcontrib>Molimard, Mathieu</creatorcontrib><creatorcontrib>Peter, Claude</creatorcontrib><title>Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention</title><title>Fundamental &amp; clinical pharmacology</title><addtitle>Fundam Clin Pharmacol</addtitle><description>The prevalence of statin use is high but adherence low. For public health intervention to be rational, subpopulations of nonadherent subjects must be defined. To categorise statin users with respect to patterns of reimbursement, this study was performed using the main French health reimbursement database for the Aquitaine region of south‐western France. The cohort included subjects who submitted a reimbursement for at least one delivery of a statin (index) during the inclusion period (1st of September 2004–31st of December 2004). Indicators of adherence from reimbursement data were considered for principal component analysis. The 119 570 subjects included and analysed had a sex ratio of 1.1, mean (SD) age of 65.9 (11.9), and 13% were considered incident statin users. Principal component analysis found three dimensions that explained 67% of the variance. Using a K‐means classification combined with a hierarchical ascendant classification, six groups were characterised. One group was considered nonadherent (10% of study population) and one group least adherent (1%). This novel application of principal component analysis identified groups that may be potential targets for intervention. The least adherent group appears to be one of the most appropriate because of both its relatively small size for case review with prescribing physicians and its very poor adherence.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular Diseases - prevention &amp; control</subject><subject>Cohort Studies</subject><subject>Databases, Factual</subject><subject>Drug Prescriptions - statistics &amp; numerical data</subject><subject>Female</subject><subject>France</subject><subject>HMG CoA reductase inhibitors</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Insurance, Health, Reimbursement - statistics &amp; numerical data</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medication Adherence - statistics &amp; numerical data</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Principal Component Analysis</subject><subject>public health</subject><subject>Public Health Practice</subject><subject>Sex Factors</subject><subject>Time Factors</subject><issn>0767-3981</issn><issn>1472-8206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc2O0zAUhS0EYsrAKyBvEKsU23HsBLFBEfMjFZgFI9hZjnNDXZw4xM7QvhJPiUNL8cbWOd-5lu5BCFOypum82a0plywrGRFrRpJKSCnJev8Irc7GY7QiUsgsr0p6gZ6FsCOESkLFU3TBqGQV5eUK_b4PgH2Hx8kOxo7aYeP70Q8wRKwH7Q7BBmwHHLeA4UG7WUfrhyWh2y1MMBjA0eMQk56oCXTsU_Yt1riHuPXt4rYQYertAEkdfUy-TR9FPX2HmIRxdsepnZ_wODfOGrwF7eI2_ZySD0vAD8_Rk067AC9O9yW6v_rwpb7JNp-vb-v3m8zwXJCsqyrNJBFdU4CQAoomb4tWEFEaxpnuaFPxsslZ1dIGiBaiJSUw0VLDTcu4yC_R6-PccfI_ZwhR9TYYcE4P4OegSlnwUsqqSOTLEzk3PbQqLbHX00H9W28CXp0AHYx23aTTksN_jueM5pwn7t2R-2UdHM4-JWqpW-3U0qpaWlVL3epv3Wqvruq79Ejx7Bi3IcL-HNfTDyVkLgv19dO1-laUH2u2qdVd_gfk5bA8</recordid><startdate>201108</startdate><enddate>201108</enddate><creator>Latry, Philippe</creator><creator>Martin-Latry, Karin</creator><creator>Labat, Anne</creator><creator>Molimard, Mathieu</creator><creator>Peter, Claude</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201108</creationdate><title>Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention</title><author>Latry, Philippe ; Martin-Latry, Karin ; Labat, Anne ; Molimard, Mathieu ; Peter, Claude</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4360-f99a2706fb5e676e5b3d5d6068c242af1b948b329d1be0a66d08e26d1c4cd2463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular Diseases - prevention &amp; control</topic><topic>Cohort Studies</topic><topic>Databases, Factual</topic><topic>Drug Prescriptions - statistics &amp; numerical data</topic><topic>Female</topic><topic>France</topic><topic>HMG CoA reductase inhibitors</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Insurance, Health, Reimbursement - statistics &amp; numerical data</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medication Adherence - statistics &amp; numerical data</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Principal Component Analysis</topic><topic>public health</topic><topic>Public Health Practice</topic><topic>Sex Factors</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Latry, Philippe</creatorcontrib><creatorcontrib>Martin-Latry, Karin</creatorcontrib><creatorcontrib>Labat, Anne</creatorcontrib><creatorcontrib>Molimard, Mathieu</creatorcontrib><creatorcontrib>Peter, Claude</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Fundamental &amp; clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Latry, Philippe</au><au>Martin-Latry, Karin</au><au>Labat, Anne</au><au>Molimard, Mathieu</au><au>Peter, Claude</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention</atitle><jtitle>Fundamental &amp; clinical pharmacology</jtitle><addtitle>Fundam Clin Pharmacol</addtitle><date>2011-08</date><risdate>2011</risdate><volume>25</volume><issue>4</issue><spage>528</spage><epage>533</epage><pages>528-533</pages><issn>0767-3981</issn><eissn>1472-8206</eissn><coden>FCPHEZ</coden><abstract>The prevalence of statin use is high but adherence low. For public health intervention to be rational, subpopulations of nonadherent subjects must be defined. To categorise statin users with respect to patterns of reimbursement, this study was performed using the main French health reimbursement database for the Aquitaine region of south‐western France. The cohort included subjects who submitted a reimbursement for at least one delivery of a statin (index) during the inclusion period (1st of September 2004–31st of December 2004). Indicators of adherence from reimbursement data were considered for principal component analysis. The 119 570 subjects included and analysed had a sex ratio of 1.1, mean (SD) age of 65.9 (11.9), and 13% were considered incident statin users. Principal component analysis found three dimensions that explained 67% of the variance. Using a K‐means classification combined with a hierarchical ascendant classification, six groups were characterised. One group was considered nonadherent (10% of study population) and one group least adherent (1%). This novel application of principal component analysis identified groups that may be potential targets for intervention. The least adherent group appears to be one of the most appropriate because of both its relatively small size for case review with prescribing physicians and its very poor adherence.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21729148</pmid><doi>10.1111/j.1472-8206.2010.00870.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0767-3981
ispartof Fundamental & clinical pharmacology, 2011-08, Vol.25 (4), p.528-533
issn 0767-3981
1472-8206
language eng
recordid cdi_proquest_miscellaneous_875487795
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Age Factors
Aged
Biological and medical sciences
Cardiovascular Diseases - prevention & control
Cohort Studies
Databases, Factual
Drug Prescriptions - statistics & numerical data
Female
France
HMG CoA reductase inhibitors
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Insurance, Health, Reimbursement - statistics & numerical data
Male
Medical sciences
Medication Adherence - statistics & numerical data
Middle Aged
Pharmacology. Drug treatments
Principal Component Analysis
public health
Public Health Practice
Sex Factors
Time Factors
title Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T21%3A03%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20principal%20component%20analysis%20in%20the%20evaluation%20of%20adherence%20to%20statin%20treatment:%20a%20method%20to%20determine%20a%20potential%20target%20population%20for%20public%20health%20intervention&rft.jtitle=Fundamental%20&%20clinical%20pharmacology&rft.au=Latry,%20Philippe&rft.date=2011-08&rft.volume=25&rft.issue=4&rft.spage=528&rft.epage=533&rft.pages=528-533&rft.issn=0767-3981&rft.eissn=1472-8206&rft.coden=FCPHEZ&rft_id=info:doi/10.1111/j.1472-8206.2010.00870.x&rft_dat=%3Cproquest_pubme%3E875487795%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=875487795&rft_id=info:pmid/21729148&rfr_iscdi=true